Document is current
Any future updates will be listed below
-
Authors
Paulk, Angelique C. http://orcid.org/0000-0002-4413-3417
Kfir, Yoav http://orcid.org/0000-0002-9373-8260
Khanna, Arjun R. http://orcid.org/0000-0003-0677-5598
Mustroph, Martina L. http://orcid.org/0000-0002-4262-5610
Trautmann, Eric M.
Soper, Dan J.
Stavisky, Sergey D.
Welkenhuysen, Marleen
Dutta, Barundeb
Shenoy, Krishna V. http://orcid.org/0000-0003-1534-9240
Hochberg, Leigh R. http://orcid.org/0000-0003-0261-2273
Richardson, R. Mark
Williams, Ziv M. http://orcid.org/0000-0002-0017-0048
Cash, Sydney S. http://orcid.org/0000-0002-4557-6391
- License Information
-
More Information
Article History
Received: 21 June 2021
Accepted: 7 December 2021
First Online: 31 January 2022
Competing interests
: K.V.S. is a consultant to Neuralink Corporation and CTRL-Labs, Inc. (now part of the Facebook Reality Labs division of Facebook) and is on the scientific advisory boards of Mind-X, Inc., Inscopix, Inc. and Heal, Inc. S.D.S. is a scientific advisor to Nēsos Corporation. The MGH Translational Research Center has clinical research support agreements with Neuralink, Paradromics and Synchron, for which S.S.C. and L.R.H. provide consultative input. None of these entities listed is involved with this research or the Neuropixels device. B.D. and M.W. are employees of IMEC, a non-profit semiconductor research and development organization that manufactures, sells and distributes the Neuropixels probes, at cost, to the research community. The remaining authors declare no competing interests.
